{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:24:11Z","timestamp":1777397051640,"version":"3.51.4"},"reference-count":41,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.5551\/jat.65941","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:08:06Z","timestamp":1759529286000},"page":"302-312","source":"Crossref","is-referenced-by-count":1,"title":["Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study"],"prefix":"10.5551","volume":"33","author":[{"given":"Tsutomu","family":"Hirano","sequence":"first","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa Medical University, Shinagawa"},{"name":"Diabetes Center, Ebina General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa Medical University, Shinagawa"},{"name":"Yurakubashi Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroe","family":"Sugita","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa Medical University, Shinagawa"},{"name":"Asoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Tamasawa","sequence":"additional","affiliation":[{"name":"Asoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohara","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa Medical University, Shinagawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michishige","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa Medical University, Shinagawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Ito","sequence":"additional","affiliation":[{"name":"Clinical Diagnostics Department, Denka Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa Medical University, Shinagawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusaku","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa Medical University, Shinagawa"},{"name":"Division of Diabetes, Metabolism, and Endocrinology, Anti-glycation Research Section, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta, 2014; 1841: 919-933","DOI":"10.1016\/j.bbalip.2014.03.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sylvers\u2011Davie KL, Davies BSJ. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8. Am J Physiol Endocrinol Metab, 2021; 321: E493-E508","DOI":"10.1152\/ajpendo.00195.2021"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tall AR, Thomas DG, Gonzalez\u2011Cabodevilla AG, Goldberg IJ. Addressing dyslipidemic risk beyond LDL\u2011cholesterol. J Clin Invest, 2022; 132: e148559","DOI":"10.1172\/JCI148559"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ginsberg HN, Goldberg IJ. Broadening the scope of dyslipidemia therapy by targeting APOC3 (apolipoprotein C3) and ANGPTL3 (angiopoietin\u2011like protein 3). Arterioscler Thromb Vasc Biol, 2023; 43: 388-398","DOI":"10.1161\/ATVBAHA.122.317966"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K, Shimizugawa T, Ando Y, Koishi R, Kohama T, Sakai N, Kotani K, Komuro R, Ishida T, Hirata K, Yamashita S, Furukawa H, Shimomura I. Angiopoietin\u2011like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol, 2007; 27: 366-372","DOI":"10.1161\/01.ATV.0000252827.51626.89"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ruppert PMM, Michielsen C, Hazebroek EJ, de Vries R, Lips M-A, de Rooij B-J, Teunis MA, Tamsma JT, Claessen N, Erkelens DW. Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue. Mol Metab, 2020; 40: 101033","DOI":"10.1016\/j.molmet.2020.101033"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Chen YQ, Pottanat TG, Siegel RW, Patel KA, Kraft TE, Wu Y, Davies BSJ. Angiopoietin\u2011like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids. J Lipid Res, 2020; 61: 1203-1220","DOI":"10.1194\/jlr.RA120000781"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Dewey FE, Gusarova V, Dunbar RL, O\u2019Dushlaine C, Schurmann C, Gottesman O, McCarthy S, Van Hout CV, Bruse S, Dansky HM, Leader JB, Murray MF, Ritchie MD, Kirchner HL, Habegger L, Lopez A, Penn J, Zhao A, Shao W, Stahl N, Murphy AJ, Hamon S, Bouzelmat A, Zhang R, Shumel B, Pordy R, Gipe D, Herman GA, Sheu WHH, Lee IT, Liang KW, Guo X, Rotter JI, Chen YI, Kraus WE, Shah SH, Damrauer S, Small A, Rader DJ, Wulff AB, Nordestgaard BG, Tybj\u00e6rg\u2011Hansen A, van den Hoek AM, Princen HMG, Ledbetter DH, Carey DJ, Overton JD, Reid JG, Sasiela WJ, Banerjee P, Shuldiner AR, Borecki IB, Teslovich TM, Yancopoulos GD, Mellis SJ, Gromada J, Baras A. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med, 2017; 377: 211-221","DOI":"10.1056\/NEJMoa1612790"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Dewey FE, Gusarova V, O\u2019Dushlaine C, Gottesman O, Trejos J, Hunt C, McCarthy S, Van Hout CV, Dunbar RL, Schurmann C, Finn D, Ritz A, Dror T, Rader DJ. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N Engl J Med, 2016; 374: 1123-1133","DOI":"10.1056\/NEJMoa1510926"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kersten S. ANGPTL3 as therapeutic target. Curr Opin Lipidol, 2021; 32: 335-341","DOI":"10.1097\/MOL.0000000000000789"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Pisciotta L, Favari E, Magnolo L, Simonelli S, Adorni MP, Sallo R, Fancello T, Zavaroni I, Ardig\u00f2 D, Bernini F, Calabresi L, Franceschini G, Tarugi P, Calandra S, Bertolini S. Characterization of three kindreds with familial combined hypolipidemia caused by loss\u2011of\u2011function mutations of ANGPTL3. Circ Cardiovasc Genet, 2012; 5: 42-50","DOI":"10.1161\/CIRCGENETICS.111.960674"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Stitziel NO, Khera AV, Wang X, Bierhals AJ, Vourakis AC, Sperry AE, Natarajan P, Klarin D, Emdin CA, Zekavat SM, Nomura A, Erdmann J, Schunkert H, Samani NJ, Kraus WE, Shah SH, Yu B, Boerwinkle E, Rader DJ, Gupta N, Frossard PM, Rasheed A, Danesh J, Lander ES, Gabriel S, Saleheen D, Musunuru K, Kathiresan S, PROMIS and Myocardial Infarction Genetics Consortium Investigators. ANGPTL3 deficiency and protection against coronary artery disease. J Am Coll Cardiol, 2017; 69: 2054-2063","DOI":"10.1016\/j.jacc.2017.02.030"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mehta N, Qamar A, Qu L, Qasim AN, Mehta NN, Reilly MP, Rader DJ. Differential association of plasma angiopoietin\u2011like proteins 3 and 4 with lipid and metabolic traits. Arterioscler Thromb Vasc Biol, 2014; 34: 1057-1063","DOI":"10.1161\/ATVBAHA.113.302802"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Smart\u2011Halajko MC, Robciuc MR, Cooper JA, Jauhiainen M, Kumari M, Kivim\u00e4ki M, Khaw KT, Boekholdt SM, Wareham NJ, Gaunt TR, Day IN, Braund PS, Nelson CP, Hall AS, Samani NJ, Humphries SE, Ehnholm C, Talmud PJ. The relationship between plasma angiopoietin\u2011like protein 4 levels, angiopoietin\u2011like protein 4 genotype, and coronary heart disease risk. Arterioscler Thromb Vasc Biol, 2010; 30: 2277-2282","DOI":"10.1161\/ATVBAHA.110.212209"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Harada\u2011Yamakawa T, Kashiwagi R, Ohira A, Sugiyama M, Sugiura Y, Kondo Y, Terauchi Y. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes. PLoS One, 2021; 16: e0255147","DOI":"10.1371\/journal.pone.0255147"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Morinaga J, Zhao J, Endo M, Kadomatsu T, Sugizaki T, Okadome Y, Tian Z, Horiguchi H, Miyashita K, Maruyama N, Mukoyama M, Oike Y. Association of circulating ANGPTL3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: a cross\u2011sectional study. PLoS One, 2018; 13: e0193731","DOI":"10.1371\/journal.pone.0193731"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ge H, Cha JY, Gopal H, Harp C, Yu X, Repa JJ, Li C. Differential regulation and properties of angiopoietin\u2011like proteins 3 and 4. J Lipid Res, 2005; 46: 1484-1490","DOI":"10.1194\/jlr.M500005-JLR200"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tanigawa R, Nakajima A, Eguchi Y, Takahashi H, Loomba R, Suganami H, Tanahashi M, Saito A, Iida Y, Yamashita S. Effects of pemafibrate on LDL\u2011C and related lipid markers in patients with MASLD: a sub\u2011analysis of the PEMA\u2011FL study. J Atheroscler Thromb, 2025; 32: 823-839","DOI":"10.5551\/jat.65395"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Morinaga J, Kashiwabara K, Torigoe D, Okadome Y, Aizawa K, Uemura K, Kurashima A, Matsunaga E, Fukami H, Horiguchi H, Sato M, Sugizaki T, Miyata K, Kadomatsu T, Mukoyama M, Miyauchi K, Hokimoto S, Fukumoto Y, Hiro T, Hibi K, Nakagawa Y, Sakuma I, Ozaki Y, Iwata H, Iimuro S, Daida H, Shimokawa H, Kimura T, Matsuzaki M, Saito Y, Matsuyama Y, Nagai R, Oike Y. Plasma ANGPTL8 levels and risk for secondary cardiovascular events in Japanese patients with stable coronary artery disease receiving statin therapy. Arterioscler Thromb Vasc Biol, 2023; 43: 1549-1559","DOI":"10.1161\/ATVBAHA.122.318880"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hirano T, Hayashi T, Sugita H, Tamasawa A, Goto S, Tomoyasu M, Yamamoto T, Ohara M, Terasaki M, Kushima H, Ito Y, Yamagishi SI, Mori Y. Prospective randomized comparative study of the effect of pemafibrate add\u2011on or double statin dose on small dense low\u2011density lipoprotein cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy. J Diabetes Investig, 2023; 14: 1401-1411","DOI":"10.1111\/jdi.14076"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hiukka A, Leinonen E, Jauhiainen M, Sundvall J, Ehnholm C, Keech AC, Taskinen MR. Long\u2011term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus. Diabetologia, 2007; 50: 2067-2075","DOI":"10.1007\/s00125-007-0751-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ito Y, Fujimura M, Ohta M, et al. Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem, 2011; 57: 57-65","DOI":"10.1373\/clinchem.2010.149559"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ito Y, Ohta M, Ikezaki H, et al. Development and population results of a fully automated homogeneous assay for LDL triglyceride. J Appl Lab Med, 2018; 2: 746-756","DOI":"10.1373\/jalm.2017.024554"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ito Y, Satoh N, Ishii T, et al. Development of a homogeneous assay for measurement of high\u2011density lipoprotein\u2011subclass cholesterol. Clin Chim Acta, 2014; 427: 86-93","DOI":"10.1016\/j.cca.2013.09.009"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Rakhshandehroo M, Stienstra R, de Wit NJ, Bragt MC, Haluzik M, Mensink RP, M\u00fcller M, Kersten S. Plasma mannose\u2011binding lectin is stimulated by PPAR\u03b1 in humans. Am J Physiol Endocrinol Metab, 2012; 302: E595-E602","DOI":"10.1152\/ajpendo.00299.2011"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, Kleemann R, Bakker A, Veenman F, Wahli W, M\u00fcller M, Kersten S. The direct PPAR target fasting\u2011induced adipose factor (FIAF\/PGAR\/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem, 2004; 279: 34411-34420","DOI":"10.1074\/jbc.M403058200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chi X, Britt EC, Shows HW, Hjelmaas AJ, Shetty SK, Cushing EM, Li W, Dou A, Zhang R, Davies BSJ. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Mol Metab, 2017; 6: 1137-1149","DOI":"10.1016\/j.molmet.2017.06.014"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation, 1998; 98: 2088-2093","DOI":"10.1161\/01.CIR.98.19.2088"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Dingman R, Bihorel S, Gusarova V, Mendell J, Pordy R. Evinacumab: mechanism of action, clinical, and translational science. Clin Transl Sci, 2024; 17: e13836","DOI":"10.1111\/cts.13836"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kersten S. Angiopoietin\u2011like 3 in lipoprotein metabolism. Nat Rev Endocrinol, 2017; 13: 731-739","DOI":"10.1038\/nrendo.2017.119"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) McCoy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res, 2002; 43: 921-929","DOI":"10.1016\/S0022-2275(20)30466-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Julve J, Escol\u00e0-Gil JC, Rotllan N, Fi\u00e9vet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Arterioscler Thromb Vasc Biol, 2010; 30: 232-238","DOI":"10.1161\/ATVBAHA.109.198226"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Watts GF, Barrett PH, Ji J, Qian Y\u2011W, Chan C. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Diabetes, 2003; 52: 803-811","DOI":"10.2337\/diabetes.52.3.803"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Keating GM, Croom KF. Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus. Drugs ,2007; 67: 121-153","DOI":"10.2165\/00003495-200767010-00013"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kontush A, Chapman MJ. Antiatherogenic small, dense HDL--guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med, 2006; 3: 144-153","DOI":"10.1038\/ncpcardio0500"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Adam RC, Mintah IJ, Alexa\u2011Braun CA, Browning K, Stitziel NO, Cohen JC, Hobbs HH. Angiopoietin\u2011like protein 3 governs LDL\u2011cholesterol levels through endothelial lipase\u2011dependent VLDL clearance. J Lipid Res, 2020; 61: 1271-1286","DOI":"10.1194\/jlr.RA120000888"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Hirano T, Kodera R, Hirashima T, Suzuki N, Aoki E, Hosoya M, Oshima T, Hayashi T, Koba S, Ohta M, Satoh N, Ito Y. Metabolic properties of low\u2011density lipoprotein (LDL) triglycerides in patients with type 2 diabetes: comparison with small dense LDL\u2011cholesterol. J Atheroscler Thromb, 2022; 29: 762-774","DOI":"10.5551\/jat.62789"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Deshaies Y, Gagn\u00e9 C, Couture P. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia. Atherosclerosis, 2006; 188: 203-212","DOI":"10.1016\/j.atherosclerosis.2005.10.037"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Dewey FE, Gusarova V, O\u2019Dushlaine C, Gottesman O, Trejos J, Hunt C, McCarthy S, Van Hout CV, Dunbar RL, Schurmann C, Finn D, Ritz A, Dror T, Rader DJ. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N Engl J Med, 2016; 374: 1123-1133","DOI":"10.1056\/NEJMoa1510926"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) van der Kolk BW, van Doorn M, de Vries R, van Dijk KW, van Mil SWC, de Roos A, Visseren FLJ, van Binsbergen E, le Cessie S, Span PN. Effect of diet\u2011induced weight loss on angiopoietin\u2011like protein 4 and adipose tissue lipid metabolism in overweight and obese humans. Physiol Rep, 2018; 6: e13735","DOI":"10.14814\/phy2.13735"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Abu\u2011Farha M, Ghosh A, Al\u2011Khairi I, Madiraju SRM, Abubaker J, Prentki M. The multi\u2011faces of Angptl8 in health and disease: novel functions beyond lipoprotein lipase modulation. Prog Lipid Res, 2020; 80: 101067","DOI":"10.1016\/j.plipres.2020.101067"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/3\/33_65941\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:39:28Z","timestamp":1772858368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/3\/33_65941\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65941","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]},"article-number":"65941"}}